What is MedShift?
Founded in 2015, MedShift operates as a comprehensive platform-as-a-service provider, specifically engineered to streamline the operational complexities of the medical industry. The company offers a diverse suite of solutions, including the MedBox Patient Subscription Platform and a specialized Aesthetic eCommerce Platform. Beyond software, MedShift provides essential device placement services and sophisticated social media channel management, effectively acting as a full-service digital partner for medical practices and device manufacturers. By integrating these disparate functions into a unified digital architecture, MedShift enables its clients to optimize patient retention and operational efficiency in an increasingly competitive healthcare landscape.
How much funding has MedShift raised?
MedShift has raised a total of $116M across 2 funding rounds:
Other Financing Round
$8M
Other Financing Round
$108M
Other Financing Round (2021): $8M, investors not publicly disclosed
Other Financing Round (2023): $108M led by Turning Rock Partners, Oy6 Capital, and Micota Capital
Key Investors in MedShift
Turning Rock Partners
Turning Rock Partners specializes in long-term investments in debt and equity securities of small and mid-capitalization businesses in North America, providing creative capital solutions in complex markets.
Micota Capital
Micota Capital is a family office focused on investing in and advising on private equity and real estate, emphasizing long-term sustainability and partnership with high-quality businesses.
Oy6 Capital
Undisclosed investor participating in the funding round.
What's next for MedShift?
With the recent infusion of capital, MedShift is well-positioned to accelerate its product development roadmap and expand its market footprint. The strategic focus will likely center on scaling its enterprise-grade SaaS offerings and enhancing the interoperability of its device placement services. As the healthcare sector continues to prioritize digital transformation, MedShift's ability to provide a cohesive, end-to-end solution for medical practices will be a key driver of its future market penetration. The company is expected to leverage this financial stability to deepen its integration with medical device manufacturers, further cementing its role as an indispensable intermediary in the healthcare supply chain.
See full MedShift company page
